January 4, 2017 08:34 AM ESTUpdated 10:31 AM
People

Ju­lian Adams jumps ship from a deeply trou­bled In­fin­i­ty Phar­ma

Arsalan Arif

Founder

Ju­lian Adams, the R&D chief of In­fin­i­ty Phar­ma­ceu­ti­cals $IN­FI for the past 14 years and a promi­nent face for one of the most high-pro­file biotechs …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

A service from the Financial Times